溃疡性结肠炎
氨基水杨酸
胃肠病学
医学
结肠炎
内科学
疾病
作者
Yongjun Wang,Claire E Parker,Brian G. Feagan,John K MacDonald
出处
期刊:The Cochrane library
[Elsevier]
日期:2016-05-09
卷期号:8 (5): CD000544-CD000544
被引量:484
标识
DOI:10.1002/14651858.cd000544.pub4
摘要
There is high-certainty evidence that 5-ASA is superior to placebo for maintenance therapy in UC. There is high-certainty evidence that 5-ASA is inferior compared to SASP. There is probably little or no difference between 5-ASA and placebo, and 5-ASA and SASP in commonly reported AEs such as flatulence, abdominal pain, nausea, diarrhea, headache, and dyspepsia. Oral 5-ASA administered once daily has a similar benefit and harm profile as conventional dosing for maintenance of remission in quiescent UC.
科研通智能强力驱动
Strongly Powered by AbleSci AI